Dormant ‘sleeper’ cells (red) and active cancer cells (green)
Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially come back to life years after initial treatment.
These are the early-stage findings from scientists at Imperial College London, who studied human breast cancer cells in the laboratory.
If we can unlock the secrets of these dormant cells, we may be able to find a way of preventing cancer coming back Dr Luca MagnaniStudy author
The team, who studied a group of breast cancer drugs called hormone treatments, say their research opens avenues for finding ways of keeping the cancer cells dormant for longer, or even potentially finding a way of awakening the cells so they can then be killed by the treatment.
Dr Luca Magnani, lead author of the study from Imperial’s Department of Surgery and Cancer said: “For a long time scientists have debated whether hormone therapies – which are a very effective treatment and save millions of lives – work by killing breast cancer cells or whether the drugs flip them into a dormant ‘sleeper’ state.
“This is an important question as hormone treatments are used on the majority of breast cancers. Our findings suggest the drugs may actually kill some cells and switch others into this sleeper state. If we can unlock the secrets of these dormant cells, we may be able to find a way of preventing cancer coming back, either by holding the cells in permanent sleep mode, or be waking them up and killing them.”
Preventing cancer relapse
In the study, published in the journal Nature Communications and funded by Cancer Research UK and the NIHR Imperial Biomedical Research Centre, the team studied around 50,000 human breast cancer single cells in the lab, and found that treating them with hormone treatment exposed a small proportion of them as being in a dormant state.
The team say the ‘sleeper cells’ may also provide clues as to why some breast cancer cells become resistant to treatment, causing a patient’s drugs to stop working, and their cancer to return.
Hormone therapies are used to treat a type of breast cancer called oestrogen-receptor positive. These make up over 70 per cent of all breast cancers, and are fuelled by the hormone oestrogen.
These cancers are usually treated with surgery to remove the tumour, followed by a course of targeted hormone therapy – usually either aromatase inhibitors or tamoxifen, which target oestrogen receptors.
However, around 30 per cent of breast cancer patients taking hormone therapies see their cancer eventually return – sometimes as long as 20 years after treatment. This returning cancer is usually metastatic, meaning it has spread around the body, and the tumours are often now resistant to medication.
Sleeper cells move around the body
Previous work by the same team has investigated why breast cancer cells become resistant to hormone treatment, with findings suggesting cells can make their own ‘fuel’, allowing them to avoid being ‘starved’ by cancer treatment.
Our experiments suggest these sleeper cells are more likely to travel around the body Dr Sung Pil Hong Study author
This new research provides another piece in the puzzle, explained Dr Iros Barozzi, co-author of the study, also from the Department of Surgery and Cancer: ‘These sleeper cells seem to be an intermediate stage to the cells becoming resistant to the cancer drugs. The findings also suggest the drugs actually trigger the cancer cells to enter this sleeper state.”
The research also revealed cells in this dormant sleeper state were more likely to spread around the body, explained Dr Sung Pil Hong, study co-author from Imperial: “Our experiments suggest these sleeper cells are more likely to travel around the body. They could then ‘awaken’ once in other organs of the body, and cause secondary cancers. However, we still don’t know how these cells switch themselves into sleep mode – and what would cause them to wake up. These are questions that need to be addressed with further research.”
The team added that hormone therapies remain one of the most effective treatments against breast cancer, and that further patient research will explore whether taking hormone therapies for longer after initial cancer treatment could prevent cancer cells from waking from their sleeping state.
Dr Rachel Shaw from Cancer Research UK, said: “Although treatments for breast cancer are usually successful, cancer returns for some women, often bringing with it a poorer prognosis. Figuring out why breast cancer sometimes comes back is essential to help us develop better treatments and prevent this from happening. This study highlights a key route researchers can now explore to tackle ‘sleeping’ cancer cells that can wake up years after treatment, which could potentially save the lives of many more women with the disease.”
Learn more: Breast cancer can form ‘sleeper cells’ after drug treatment
The Latest on: Breast cancer
via Google News
The Latest on: Breast cancer
- Investigation underway after delays to breast cancer screening may have affected patients' prognosis, treatmenton May 23, 2022 at 11:34 pm
About 52 breast cancer patients in the wider Wellington region may have had their treatment and prognosis affected by delays to a mammogram service.
- FOX 35 anchor Amy Kaufeldt shares breast cancer diagnosison May 23, 2022 at 9:01 am
"Good Day Orlando" anchor Amy Kaufeldt shared some personal news on air regarding a recent breast cancer diagnosis.
- Breast Cancer Diagnostics Market is Estimated to Rise at a CAGR of 7% during the Forecast Period, notes TMR Studyon May 23, 2022 at 8:59 am
The global breast cancer diagnostics market is expected to develop due to the high prevalence and increasing occurrence rate of breast cancer, as well as technical improvements in diagnostic ...
- Exploring Resistance to HER2-Targeted Therapy for Breast Canceron May 23, 2022 at 8:04 am
Ron Bose, MD, PhD, discusses the rationale for a trial of neratinib plus alpelisib for patients with HER2-positive breast cancer.
- OncoSec Receives Triple Negative Breast Cancer Foundation's Vanguard Award for Excellence in Oncology Researchon May 23, 2022 at 5:08 am
OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec") today announced that it is the recipient of the 2022 Vanguard Award presented by the Triple Negative Breast Cancer (TNBC) ...
- A Breast Cancer Surgeon’s Effort Brings Holistic Healing to Survivorson May 23, 2022 at 4:34 am
I get to address the whole person and I get to cut out the cancer, “ says Dr. Monique Gary, “and that makes me feel pretty privileged.“ ...
- NWA Metsquerade co founder faces stage IV breast cancer setbackon May 22, 2022 at 8:46 pm
IN 2015, THE TWO WOMEN - BOTH DIAGNOSED WITH STAGE FOUR BREAST CANCER - FOUNDED THE NORTHWEST ARKANSAS METSQUERADE TO RAISE MONEY FOR RESEARCH. SADLY, LISA PASSED AWAY FROM METASTATIC BREAST CANCER ...
- Hyperinsulinemic patients with breast cancer may be responsive to metabolism-targeting treatmentson May 20, 2022 at 7:14 am
Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the ...
- Breast cancer: Who can avoid chemotherapy post-surgery?on May 19, 2022 at 6:00 pm
When 36-year old Ritu was diagnosed with breast cancer, she was devastated thinking about the toll that chemotherapy would have on her physical and mental health. Fortunately, her doctor recommended a ...
- I got breast implants after beating breast cancer. They made me even sicker than I was before.on May 17, 2022 at 8:52 am
The author's breast implant side effects included fatigue, dry eyes, increased anxiety, weakened bladder control, and acne outbreaks.
via Bing News